Studies have shown that neoadjuvant nivolumab may provide long-term benefits for people with non-small cell lung cancer.

Published Date: 17 Feb 2023

BACKGROUND: NSCLC is the most common and important cause of cancer worldwide. Assessment: The patient...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Study identifies new target for obesity-related breast cancer

2.

Too Many Kids With Sickle Cell Disease Aren't Getting Appropriate Preventive Care

3.

Zebrafish models offer fast, effective guidance for personalized therapies for kids with high-risk cancer

4.

Home Screening Appeals to Women Facing Healthcare Barriers

5.

Research suggests peer support may lower depression, stress among cancer patients in low-resource settings


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot